[ad_1]
Aecom is one of a few names that could see gains as a result of earnings, and that could provide an opportunity for investors as the market possibly broadens out, according to Ellen Hazen, chief market strategist at F.L.Putnam Investment Management. Hazen appeared on CNBC’s ” Power Lunch ” on Tuesday to offer her take on where some of the biggest trending stocks could be going from here. Below are her thoughts on the three names she thinks traders should keep an eye on. Aecom While the future of the Inflation Reduction Act and the Infrastructure Investment and Jobs Act is uncertain under President Donald Trump, Hazen still believes the country’s infrastructure needs investment, which could benefit infrastructure consulting firm Aecom. The strategist said earnings will serve as a tailwind for the stock, which has been rather flat year to date. Over the past 12 months, the stock has risen nearly 19%. ACM 1Y mountain Aecom stock over the past year. “You’re going to see 15% to 20% earnings growth [and] 15% to 20% revenue growth, so very, very strong growth,” she said. “Estimates keep going up.” Hazen also believes the market hasn’t taken into account the significance of the company’s business model becoming “less capital intensive than it used to be.” Its multiple is the same as it has been for the past five years despite this shift, she said. The stock currently trades at around 20 times forward earnings, which is a slight discount relative to the S & P 500 . It has also fallen nearly 1% in 2025. Stryker Unlike Aecom, shares of Stryker have outperformed the broader market this year, rising more than 8% year to date. The medical technology company has also gained more than 14% over the past 12 months. Notably, its forward price-to-earnings ratio stands at about 29. Though “not cheap,” the strategist believes it is still “high quality.” “Look, you’re paying for quality,” the strategist said. “They’re gaining market share, and you have this demographic tailwind that’s going to continue to benefit the company in terms of top-line growth as we go forward.” On top of the demographic tailwind, Hazen anticipates there being an earnings tailwind for the name, as she thinks gross margins can return to pre-Covid levels. Evercore Evercore is another example where earnings estimates are being revised upward, Hazen noted. But the investment bank could see more upside from an increase in merger and acquisition activity. “If you look at mergers and acquisitions volumes, they’re healthy, they’re okay, but they’re down something like 30% from 2001 levels,” the strategist said. “So, we think there’s a long way to go up.” “We think there’s scope for rebound as companies face the threats of tariffs, of trying to find enough labor, of immigration and of artificial intelligence and a lot of other things,” Hazen continued. “They are going to continue to do more mergers and acquisitions.” Evercore shares have fallen more than 4% this year but have risen nearly 49% over the past 12 months. The stock also has a forward P/E ratio of about 19. EVR 1Y mountain Evercore stock over the past year.
[ad_2]
Source link
